Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
University of California, Irvine
Sichuan Enray Pharmaceutical Sciences Company
Essen Biotech
University of Colorado, Denver
University of Nebraska
Medical College of Wisconsin
Mayo Clinic
City of Hope Medical Center
University Health Network, Toronto
Hospices Civils de Lyon
Washington University School of Medicine
Washington University School of Medicine
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Dana-Farber Cancer Institute
Sichuan Enray Pharmaceutical Sciences Company
The Netherlands Cancer Institute
Institut Bergonié
University of California, Irvine
Yonsei University
Cancer Research UK
N.N. Petrov National Medical Research Center of Oncology
Arbeitsgemeinschaft medikamentoese Tumortherapie
Tomsk National Research Medical Center of the Russian Academy of Sciences
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey
Stanford University
University Health Network, Toronto
Washington University School of Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Second Affiliated Hospital of Guangzhou Medical University
Cedars-Sinai Medical Center
Comprehensive Support Project for Oncology Research
Cancer Support Community, Research and Training Institute, Philadelphia
Beijing Friendship Hospital
Memorial Sloan Kettering Cancer Center
Institut Paoli-Calmettes
Lebanese University
Istituti Clinici Scientifici Maugeri SpA
Avera McKennan Hospital & University Health Center
Umeå University
SCRI Development Innovations, LLC
Kaohsiung Medical University Chung-Ho Memorial Hospital
Barbara Ann Karmanos Cancer Institute
Biologics & Biosimilars Collective Intelligence Consortium
M.D. Anderson Cancer Center
Assistance Publique - Hôpitaux de Paris